{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:15:18Z","timestamp":1791296118300,"version":"4.1.0"},"reference-count":38,"publisher":"National Academy of Sciences","issue":"11","content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2011,3,15]]},"abstract":"<jats:p>\n                    Ozonide OZ439 is a synthetic peroxide antimalarial drug candidate designed to provide a single-dose oral cure in humans. OZ439 has successfully completed Phase I clinical trials, where it was shown to be safe at doses up to 1,600 mg and is currently undergoing Phase IIa trials in malaria patients. Herein, we describe the discovery of OZ439 and the exceptional antimalarial and pharmacokinetic properties that led to its selection as a clinical drug development candidate. In vitro, OZ439 is fast-acting against all asexual erythrocytic\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    stages with IC\n                    <jats:sub>50<\/jats:sub>\n                    values comparable to those for the clinically used artemisinin derivatives. Unlike all other synthetic peroxides and semisynthetic artemisinin derivatives, OZ439 completely cures\n                    <jats:italic>Plasmodium berghei<\/jats:italic>\n                    -infected mice with a single oral dose of 20 mg\/kg and exhibits prophylactic activity superior to that of the benchmark chemoprophylactic agent, mefloquine. Compared with other peroxide-containing antimalarial agents, such as the artemisinin derivatives and the first-generation ozonide OZ277, OZ439 exhibits a substantial increase in the pharmacokinetic half-life and blood concentration versus time profile in three preclinical species. The outstanding efficacy and prolonged blood concentrations of OZ439 are the result of a design strategy that stabilizes the intrinsically unstable pharmacophoric peroxide bond, thereby reducing clearance yet maintaining the necessary Fe(II)-reactivity to elicit parasite death.\n                  <\/jats:p>","DOI":"10.1073\/pnas.1015762108","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:35:23Z","timestamp":1297125323000},"page":"4400-4405","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":352,"title":["Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria"],"prefix":"10.1073","volume":"108","author":[{"given":"Susan A.","family":"Charman","sequence":"first","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Arbe-Barnes","sequence":"additional","affiliation":[{"name":"Fulcrum Pharma Developments Ltd., Hemel Hempstead, Hertfordshire HP1 1JY, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C.","family":"Bathurst","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, CH-1215 Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Brun","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland;"},{"name":"University of Basel, CH-4051 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Campbell","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N.","family":"Charman","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis C. K.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Chollet","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland;"},{"name":"University of Basel, CH-4051 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Carl","family":"Craft","sequence":"additional","affiliation":[{"name":"Medicines for Malaria Venture, CH-1215 Geneva, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren J.","family":"Creek","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Dong","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Matile","sequence":"additional","affiliation":[{"name":"F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Maurer","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland;"},{"name":"University of Basel, CH-4051 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Morizzi","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Papastogiannidis","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland;"},{"name":"University of Basel, CH-4051 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Scheurer","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland;"},{"name":"University of Basel, CH-4051 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Shackleford","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamaraj","family":"Sriraghavan","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Stingelin","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqing","family":"Tang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Urwyler","sequence":"additional","affiliation":[{"name":"Basilea Pharmaceutica Ltd., CH-4058 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"White","sequence":"additional","affiliation":[{"name":"Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Wittlin","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, CH-4002 Basel, Switzerland;"},{"name":"University of Basel, CH-4051 Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Vennerstrom","sequence":"additional","affiliation":[{"name":"College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6025;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2011,2,7]]},"reference":[{"key":"e_1_3_3_1_2","volume-title":"Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000\u20132010","year":"2010","unstructured":"Global Report on Antimalarial Drug Efficacy and Drug Resistance: 2000\u20132010 (World Health Organization, Geneva, 2010)."},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2331"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.328.5980.844"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.318.5856.1544"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2972"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1155165"},{"key":"e_1_3_3_7_2","volume-title":"Guidelines for the Treatment of Malaria","year":"2006","unstructured":"Guidelines for the Treatment of Malaria (World Health Organization, Geneva, 2006)."},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/415686a"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.7.1413"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-125"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02779"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.51"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049040u"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00225-07"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn315"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl209"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-007-0452-8"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1086\/655831"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.01.087"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.10.1059"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20538"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01813"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.2174\/0929867013371608"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2006.03.005"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(02)00194-7"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm030571c"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules15031705"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500972102"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01305-09"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.20958"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm0707673"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01033-07"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2008.06.008"},{"key":"e_1_3_3_34_2","first-page":"709","article-title":"The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin","volume":"107","author":"Chen PQ","year":"1994","unstructured":"PQ Chen, et al., The infectivity of gametocytes of Plasmodium falciparum from patients treated with artemisinin. Chin Med J (Engl) 107, 709\u2013711 (1994).","journal-title":"Chin Med J (Engl)"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21682"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.inhe.2010.04.002"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlac.199719970715"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/med.10066"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1015762108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T19:43:11Z","timestamp":1649792591000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1015762108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,7]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,3,15]]}},"alternative-id":["10.1073\/pnas.1015762108"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1015762108","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.11732966.12815069","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.11732966.14726322","asserted-by":"object"}]},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,7]]},"assertion":[{"value":"2011-02-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}